Showing results (71-80 of 95) with videos related to

Sort By:
Pageof 10
Translational Oncology|May 11, 2019
Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate CancerAlan P Lombard, Chengfei Liu, Cameron M Armstrong, et al.
Journal for Immunotherapy of Cancer|May 5, 2023
Androgen receptor blockade resistance with enzalutamide in prostate cancer results in immunosuppressive alterations in the tumor immune microenvironmentPengfei Xu, Joy C Yang, Bo Chen, et al.
Molecular Cancer Therapeutics|May 21, 2020
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate CancerJinge Zhao, Shu Ning, Wei Lou, et al.
Molecular Cancer Therapeutics|July 17, 2019
AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate CancerChengfei Liu, Joy C Yang, Cameron M Armstrong, et al.
Molecular Cancer Therapeutics|May 14, 2017
Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate CancerChengfei Liu, Cameron M Armstrong, Wei Lou, et al.
Cancers|June 26, 2025
Steroid Sulfatase Regulates Metabolic Reprogramming in Advanced Prostate CancerMasuda Sharifi, Cameron M Armstrong, Shu Ning, et al.
Iscience|February 8, 2024
IGFBP3 promotes resistance to Olaparib via modulating EGFR signaling in advanced prostate cancerAmy R Leslie, Shu Ning, Cameron M Armstrong, et al.
Pharmacological Research|February 11, 2023
Allosteric inhibition of HSP70 in collaboration with STUB1 augments enzalutamide efficacy in antiandrogen resistant prostate tumor and patient-derived modelsPengfei Xu, Joy C Yang, Shu Ning, et al.
Research Square|April 8, 2024
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancerChengfei Liu, Bo Chen, Pengfei Xu, et al.
Cancers|October 16, 2025
Dynamic Reprogramming of Immune-Related Signaling During Progression to Enzalutamide Resistance in Prostate CancerPengfei Xu, Huan Qu, Joy C Yang, et al.
Pageof 10